Inventor · disambiguated record
Xiaoyun Zhu
Also filed as: ZHU XIAOYUN
29 granted patents·11 pending applications·730 citations·filing 2004–2024
98Inventor score
Files withALTOR BIOSCIENCE LLC13ALTOR BIOSCIENCE CORP12WONG HING C6IMMUNITYBIO INC3HCW BIOLOGICS INC2
Top patents by PatentIndex Score
40 records- 0199US11845783B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2021·Granted Dec 19, 2023·6 cites·5 claims
- 0299US11104716B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2020·Granted Aug 31, 2021·12 cites·17 claims
- 0399US11046747B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2020·Granted Jun 29, 2021·18 cites·13 claims
- 0499US10150805B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE CORP·Filed 2016·Granted Dec 11, 2018·44 cites·20 claims
- 0598US11673932B2Fusion molecules and IL-15 variantsALTOR BIOSCIENCE LLC·Filed 2022·Granted Jun 13, 2023·10 cites·13 claims
- 0698US10899821B2Method of treating neoplasia with a multimeric IL-15 soluble fusion moleculeALTOR BIOSCIENCE LLC·Filed 2018·Granted Jan 26, 2021·15 cites·21 claims
- 0798US10450359B2IL-15 variants and uses thereofALTOR BIOSCIENCE CORP·Filed 2016·Granted Oct 22, 2019·29 cites·14 claims
- 0898US10358478B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE CORP·Filed 2016·Granted Jul 23, 2019·26 cites·18 claims
- 0998US9464127B2Fusion molecules and IL-15 variantsALTOR BIOSCIENCE CORP·Filed 2013·Granted Oct 11, 2016·49 cites·21 claims
- 1098US9428573B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE CORP·Filed 2013·Granted Aug 30, 2016·56 cites·32 claims
- 1198US9328159B2Multimeric IL-15 soluble fusion molecules and methods of using sameALTOR BIOSCIENCE CORP·Filed 2013·Granted May 3, 2016·54 cites·9 claims
- 1298US9255141B2Multimeric IL-15 soluble fusion molecules and methods of treating neoplasia and HIV using sameWONG HING C·Filed 2013·Granted Feb 9, 2016·44 cites·16 claims
- 1398US8940289B2Fusion molecules and IL-15 variantsWONG HING C·Filed 2012·Granted Jan 27, 2015·46 cites·8 claims
- 1498US8507222B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameWONG HING C·Filed 2011·Granted Aug 13, 2013·109 cites·6 claims
- 1598US8492118B2Fusion molecules and IL-15 variantsWONG HING C·Filed 2008·Granted Jul 23, 2013·52 cites·26 claims
- 1698US8163879B2Fusion molecules and IL-15 variantsWONG HING C·Filed 2010·Granted Apr 24, 2012·81 cites·9 claims
- 1797US11498950B1Fusion molecules and IL-15 variantsALTOR BIOSCIENCE LLC·Filed 2019·Granted Nov 15, 2022·9 cites·7 claims
- 1896US11365231B2Interleukin 15 (IL-15) variantsALTOR BIOSCIENCE LLC·Filed 2019·Granted Jun 21, 2022·10 cites·7 claims
- 1996US9593152B2Methods of treating disease with fusion molecules comprising IL-15 variantsALTOR BIOSCIENCE CORP·Filed 2014·Granted Mar 14, 2017·23 cites·5 claims
- 2093US11053299B2SuperkineIMMUNITY BIO INC·Filed 2019·Granted Jul 6, 2021·16 cites·18 claims
- 2192US2025066442A1Fusion molecules and il-15 variantsALTOR BIOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 2291US12371472B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2023·Granted Jul 29, 2025·0 cites·11 claims
- 2391US11168138B2Anti-PDL1, IL-15 and TGF-beta receptor combination moleculesALTOR BIOSCIENCE LLC·Filed 2019·Granted Nov 9, 2021·18 cites·17 claims
- 2490US12024545B2Methods of treating aging-related disordersHCW BIOLOGICS INC·Filed 2021·Granted Jul 2, 2024·2 cites·78 claims
- 2588US12168680B2Fusion molecules and IL-15 variantsALTOR BIOSCIENCE LLC·Filed 2023·Granted Dec 17, 2024·0 cites·17 claims
- 2673US2025011380A1Methods of treating aging-related disordersIMMUNITYBIO INC·Filed 2024·Application pending·0 cites
- 2769US2020283498A1T cell receptor fusions and conjugates and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2020·Application pending·0 cites
- 2869US2020172594A1T cell receptor fusions and conjugates and methods of use thereofALTOR BIOSCIENCE CORP·Filed 2019·Application pending·0 cites
- 2968US2011070191A1T cell receptor fusions and conjugates and methods of use there ofWONG HING C·Filed 2009·Application pending·0 cites
- 3067US2025136663A1Multi-chain chimeric polypeptides and uses thereofIMMUNITYBIO INC·Filed 2024·Application pending·0 cites
- 3166US2015079025A1T cell receptor fusions and conjugates and methods of use thereofALTOR BIOSCIENCE CORP·Filed 2014·Application pending·0 cites
- 3266US2019269807A1Soluble tcr molecules and methods of useALTOR BIOSCIENCE CORP·Filed 2019·Application pending·0 cites
- 3359US9290560B2Soluble TCR molecules and methods of useALTOR BIOSCIENCE CORP·Filed 2014·Granted Mar 22, 2016·0 cites·10 claims
- 3456US2016199523A1Soluble tcr molecules and methods of useALTOR BIOSCIENCE CORP·Filed 2016·Application pending·0 cites
- 3554US2021008167A1T cell receptor fusions and conjugates and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2019·Application pending·0 cites
- 3652US12497462B2Anti-CD26 proteins and uses thereofIMMUNITYBIO INC·Filed 2021·Granted Dec 16, 2025·0 cites·21 claims
- 3751US2023125173A1Multi-chain chimeric polypeptides and use thereof in the treatment of liver diseasesHCW BIOLOGICS INC·Filed 2022·Application pending·0 cites
- 3847US8772451B2Soluble TCR molecules and methods of usePRICE-SCHIAVI SHARI A·Filed 2004·Granted Jul 8, 2014·1 cites·14 claims
- 3945US12161646B2Polycyclic carbamoylpyridone derivatives, pharmaceutical compositions and use thereofJIAXING ANDICON BIOTECH CO LTD·Filed 2019·Granted Dec 10, 2024·0 cites·19 claims
- 4017US10414756B22-(2,4,5-substituted aniline) pyrimidine derivative, pharmaceutical composition and use thereofNANJING DIANSU BIOLOGICAL TECH CO LTD·Filed 2015·Granted Sep 17, 2019·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Xiaoyun Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →